Laurus Labs gets USFDA nod for Unit-4

Our Bureau Hyderabad | Updated on July 12, 2019 Published on July 12, 2019

Laurus Labs has `successfully’ completed the maiden US Food and Drug Administration (USFDA) audit for its Unit-4 without any observations and no form 483 was issued.

The inspection was carried out from July 8-12 this year , the Hyderabad-based company said in a release here on Friday.

The Unit-4 of Laurus Labs, located at Achutapuram SEZ, Visakhapatnam, is meant for manufacturing of Active Pharma Ingredients.

Published on July 12, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.